STAAR Surgical Company specializes in ophthalmic surgery products, focusing on minimally invasive vision correction solutions. The company's flagship product line is the EVO family of Implantable Collamer Lenses (EVO ICL), which are phakic intraocular lenses designed to reduce or eliminate the need for glasses or contact lenses without removing corneal tissue. In addition to refractive surgery products, STAAR provides intraocular lenses (IOLs) and delivery systems for cataract surgery. The company sells its products in over 75 countries, with a particularly strong market position in China and other Asian countries, as well as growing adoption in the Americas and EMEA. By offering a reversible, cornea-sparing alternative to traditional laser vision correction like LASIK, STAAR Surgical has established a distinctive competitive position in the premium refractive care market.
